BR9916141A - Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos - Google Patents

Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos

Info

Publication number
BR9916141A
BR9916141A BR9916141-9A BR9916141A BR9916141A BR 9916141 A BR9916141 A BR 9916141A BR 9916141 A BR9916141 A BR 9916141A BR 9916141 A BR9916141 A BR 9916141A
Authority
BR
Brazil
Prior art keywords
canis
homologous
protein
ehrlichia canis
genes
Prior art date
Application number
BR9916141-9A
Other languages
English (en)
Portuguese (pt)
Inventor
David H Walker
Xue-Jie Yu
Jere W Mcbride
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/201,458 external-priority patent/US6458942B1/en
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of BR9916141A publication Critical patent/BR9916141A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9916141-9A 1998-11-30 1999-11-24 Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos BR9916141A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/201,458 US6458942B1 (en) 1998-11-30 1998-11-30 28-kDa immunoreactive protein gene of Ehrlichia canis and uses thereof
US09/261,358 US6403780B1 (en) 1998-11-30 1999-03-03 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
PCT/US1999/028075 WO2000032745A2 (en) 1998-11-30 1999-11-24 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof

Publications (1)

Publication Number Publication Date
BR9916141A true BR9916141A (pt) 2001-12-04

Family

ID=26896771

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916141-9A BR9916141A (pt) 1998-11-30 1999-11-24 Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos

Country Status (11)

Country Link
EP (1) EP1470223A4 (enExample)
JP (1) JP2003527073A (enExample)
CN (1) CN1535314A (enExample)
AU (1) AU762315B2 (enExample)
BR (1) BR9916141A (enExample)
CA (1) CA2352466A1 (enExample)
IL (1) IL143415A0 (enExample)
NZ (1) NZ511922A (enExample)
RU (1) RU2237716C2 (enExample)
TW (1) TWI221481B (enExample)
WO (1) WO2000032745A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544517B1 (en) 1998-09-18 2003-04-08 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US7888491B2 (en) 1998-09-18 2011-02-15 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6392023B1 (en) * 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
US7335754B2 (en) 1999-07-21 2008-02-26 Cornell Research Foundation, Inc. Ehrlichia canis genes and vaccines
CA2407946A1 (en) 2000-05-01 2001-11-08 Research Development Foundation Ehrlichia chaffeensis 28 kda outer membrane protein multigene family
US6432649B1 (en) * 2000-08-25 2002-08-13 The Ohio State University Research Foundation Methods for detecting Ehrlichia canis and Ehrlichia chaffeensis in vertebrate and invertebrate hosts
US8784828B2 (en) 2007-05-04 2014-07-22 The Ohio State University Research Foundation Ehrlichia ewingii proteins, nucleic acids, and methods of their use
US20140162256A1 (en) 2011-03-31 2014-06-12 Yasuko Rikihisa Compositions and methods for the detection of anaplasma platys
CN105051541B (zh) 2012-10-11 2017-07-04 爱贝斯股份有限公司 用于检测埃里希体属抗体的肽、装置和方法
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
WO2025118050A1 (pt) * 2023-12-04 2025-06-12 Laboratório Bio-Vet Ltda Antígeno vacinal quimérico com ação tríplice contra erliquiose, anaplasmose e babesiose canina, vetor de expressão, célula recombinante, composição vacinal, kit de diagnóstico, método de tratamento e uso de proteína quimérica

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025338A (en) * 1996-10-17 2000-02-15 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
ATE481416T1 (de) * 1997-09-19 2010-10-15 Univ Ohio State Res Found Proteine der äusseren membran von ehrlichia chaffeensis

Also Published As

Publication number Publication date
CA2352466A1 (en) 2000-06-08
TWI221481B (en) 2004-10-01
NZ511922A (en) 2003-10-31
JP2003527073A (ja) 2003-09-16
EP1470223A4 (en) 2005-04-06
RU2237716C2 (ru) 2004-10-10
EP1470223A2 (en) 2004-10-27
CN1535314A (zh) 2004-10-06
WO2000032745A3 (en) 2004-05-21
AU1923400A (en) 2000-06-19
AU762315B2 (en) 2003-06-19
IL143415A0 (en) 2002-04-21
WO2000032745A2 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
BR0113818A (pt) Genes de proteìna imunodominante de vinte e oito quilodáltons, homóloga à ehrlichia canis e uso dos mesmos
BR9916141A (pt) Genes de proteìna imunodominante de 28kilodaltons homólogos de ehrlichia canis e usosdos mesmos
Krohne et al. Nuclear lamin LI of Xenopus laevis: cDNA cloning, amino acid sequence and binding specificity of a member of the lamin B subfamily.
Baumgartner et al. Tena, a Drosophila gene related to tenascin, shows selective transcript localization
DK0861261T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Delta-gener og fremgangsmåder baseret derpå
Sellos et al. Molecular cloning of hemocyanin cDNA from Penaeus vannamei (Crustacea, Decapoda): structure, evolution and physiological aspects
ES2419657T3 (es) Proteínas recombinantes con actividad hemostática capaces de inducir la agregación plaquetaria
EP1767546A4 (en) AN ANGIOGENESIS INHIBITING CHIMERIC PROTEIN AND ITS USE
DK0813545T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Serrate-gener og fremgangsmåde baseret derpå
ATE366319T1 (de) Adeno-assoziierte virus-vermittelte übertragung von angiogenesefaktoren
RU95115239A (ru) Аналог эритропоэтина
DK1407033T3 (da) Intergeniske områder som insertionssteder i genomet af Modified Vaccinia Virus Ankara (MVA)
DE60230860D1 (de) Von tryptophanyl-trna-synthetase stammende polypeptide zur regulierung der angiogenese
BR9809914A (pt) Genes de moracella receptores de lactoferrina
Blanton et al. Characterization of a native and recombinant Schistosoma haematobium serine protease inhibitor gene product
ATE404217T1 (de) Therapie mit lipoproteinlipase (lpl) variant
Goraczniak et al. Structural and functional characterization of a second subfamily member of the calcium-modulated bovine rod outer segment membrane guanylate cyclase, ROS-GC2
Hawn et al. Molecular cloning and expression of SmIrV1, a Schistosoma mansoni antigen with similarity to calnexin, calreticulin, and OvRal1.
AR020066A1 (es) Un polipeptido purificado, util para prevenir la tuberculosis y las composiciones farmaceuticas que contienen dichos polipeptidos y los polinucleotidos quelos codifican
EA200401505A1 (ru) Экспрессия генов модифицированного вируса осповакцины ankara с использованием ati-промотора вируса коровьей оспы
ES2822924T3 (es) Composición para prevenir o tratar una enfermedad arterial periférica utilizando el factor de crecimiento de hepatocitos y el factor 1a derivado de células del estroma
Cao et al. Characterization, cloning and expression of the 67-kDA annexin from chicken growth plate cartilage matrix vesicles
Sun et al. Molecular cloning and characterization of Fc-TSP from the Chinese shrimp Fennerpenaeus chinensis
PE20010066A1 (es) Polipeptido de proteina c activada
SE8801723D0 (sv) Fibronectin binding protein as well as its preparation

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 10 (VIII E IX), 11, 13 E 24 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.